ECM
CYTK icon

EMC Capital Management’s Cytokinetics CYTK Stock Holding History

EMC Capital Management’s Portfolio CYTK Stock Details CYTK Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q1 		– Sell
-24,627
Closed -$1.12M – 331
2021
Q4 		$1.12M Hold
24,627
– – 0.6% 41
2021
Q3 		$860K Hold
24,627
– – 0.48% 55
2021
Q2 		$487K Sell
24,627
-4,237
-15% -$99.5K 0.28% 80
2021
Q1 		$671K Buy
28,864
+7,424
+35% +$159K 0.48% 65
2020
Q4 		$446K Buy
+21,440
New +$392K 0.34% 75

Other funds holding CYTK

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
RI
RTW Investments New York $10B AUM 135.35% 1-Year Est. Return
PAMS
Pictet Asset Management (Switzerland) Geneva 73, Switzerland $84.3B AUM 26.5% 1-Year Est. Return
PHS
PFM Health Sciences San Francisco, California $1.1B AUM 57.92% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return
BC
Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return
DCM
Driehaus Capital Management Chicago, Illinois $13.6B AUM 173.98% 1-Year Est. Return

EMC Capital Management's CYTK Position: Q1 2022 in Review

EMC Capital Management sold out of Cytokinetics (CYTK) in Q1 2022, closing a stake of 24,627 shares — an estimated $1.12M sold.

EMC Capital Management first reported a position in CYTK in Q4 2020 and held it in 5 quarters. The position peaked at $1.12M in Q4 2021. 240 funds tracked by Wall St. Rank hold CYTK as of Q1 2022.

  • EMC Capital Management reported no remaining Cytokinetics position as of Q1 2022 after selling out during the quarter.
  • EMC Capital Management sold 24,627 Cytokinetics shares in Q1 2022, an estimated $1.12M.
  • EMC Capital Management first reported a position in Cytokinetics in Q4 2020 and held it in 5 quarters.
  • EMC Capital Management's Cytokinetics position peaked at $1.12M in Q4 2021.
  • 240 funds tracked by Wall St. Rank held Cytokinetics as of Q1 2022.

Based on EMC Capital Management's 13F filing for Q1 2022, filed 16 May 2022.